Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Tolerance 97% well tolerated Exceptional safety profile in clinical studies
Known and theoretical concerns BPC-157 considerations: BPC-157 promotes angiogenesis (new blood vessel formation), which supports healing but raises theoretical concerns for anyone with cancer or precancerous conditions
People with severe kidney, heart, or liver conditions need clearance from their primary doctor first
GLP-1 Key Research Facts Full name: Glucagon-Like Peptide-1 incretin hormone of the proglucagon family Primary bioactive form: GLP-1(736)amide 30 amino acids, C-terminally amidated Gene source: Proglucagon gene processed by PCSK1 in intestinal L-cells and brainstem NTS neurons In vivo half-life: Approximately 12 minutes rapidly inactivated by DPP-4 (cleaves His7-Ala8 dipeptide) Primary receptor: GLP-1R (GLP-1 receptor) class B G protein-coupled receptor (GPCR) Signalling: GLP-1R activation cAMP elevation PKA/CREB activation glucose-dependent insulin secretion Additional signalling: PI3K/Akt pathway -cell survival, proliferation, and glucose sensitivity Secretion pattern: Biphasic post-meal release from intestinal L-cells early neural/endocrine peak + late direct nutrient-contact peak Fasting plasma level: ~510 pmol/L
US$ 21.48
US$ 24.83
US$ 22.07
US$ 22.20
US$ 27.43
US$ 21.53
US$ 26.27
